期刊文献+

抗MUC1单克隆抗体C595对人卵巢癌0VCAR-3细胞增殖和凋亡的研究 被引量:2

Effects of Anti-MUC1 Monoclonal Antibody C595 on the Proliferation and Apoptosis of Human Ovarian Cancer Cell Line OVCAR-3
下载PDF
导出
摘要 目的:探讨抗MUCI单克隆抗体C595在体外抑制高表达MUC1的人卵巢癌OVCAR-3细胞增殖并诱导其凋亡的作用。方法:免疫荧光标记法和流式细胞术检测单克隆抗体C595标记的MUC1在OVCAR-3细胞表面的表达;MTT法、克隆形成试验检测处理后细胞生长抑制情况,TUNEL法检测细胞凋亡,EIISA检测细胞内细胞色素C和Caspase-3活性的变化。结果:单克隆抗体C595对人卵巢癌OVCAR-3细胞具有明显的增殖抑制作用,且呈剂量-时间依赖性,TUNEL结果表明C595(IC_(50))可以诱导细胞凋亡。ELLSA检测显示治疗后的细胞凋亡与释放细胞色素C和Caspase-3浓度的上升相关。结论:单克隆抗体C595可以在体外抑制人卵巢癌OvCAR-3细胞增殖并诱导其凋亡,其机制可能与上调Caspase-3蛋白活性有关。 Objective: To investigate the effect of anti-MUC 1 monoclonal antibody ( Mab ) C595 on the growth and apoptosis of human ovarian cancer cell line OVCAR-3. Methods:The expression of MUC 1 on OVCAR-3 cells was examined by immunofluores- cence labeling and flow cytometry using MabC595. The cell proliferation was measured by MTT assay and colony formation assay. TU- NEL method was used to detect apoptosis. Cytochrome c and Caspase-3 activity were measured by ELISA. Results: Mab C595 inhibit- ed the growth of OVCAR-3 cells in a concentration-and time-dependent manner. TUNEL showed that Mab C595 induced apoptosis of OVCAR-3. ELISA analysis showed that cell death following treatment was associated with the release of cytochrome c and Caspase-3 concentrations. Conclusion: Mab C595 inhibits the proliferation and induces cell apoptosis in human ovarian cancer cell line OV- CAR-3. The mechanisms of cell apoptosis induced by Mab C595 may be through upregulating Caspase-3 activity.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2012年第7期361-364,共4页 Chinese Journal of Clinical Oncology
基金 河南省卫生厅重点科技攻关基金(编号:201001023)资助~~
关键词 MUC1 单克隆抗体C595 卵巢癌 凋亡 MUC-1 Monoclonal antibody C595 Ovarian cancer Apoptosis
  • 相关文献

参考文献10

  • 1Boumendjel A,Baubichon-Cortay H,Trompier D. Anticancer multidrug resistance mediated by MRP1:recent advances in the dis-covery of reversal agents[J].Medicinal Research Reviews,2005,(04):453-472.doi:10.1002/med.20032.
  • 2Wang L,Ma J,Liu FH. Expression of MUC1 in primary and metastatic human epithelial ovarian cancer and its therapeutic signif-icance[J].Gynecologic Oncology,2007,(03):695-702.
  • 3Aubert S,Fauquette V,Hemon B. MUC1,a new hypoxia in-ducible factor target gene,is an actor in clear renal cell carcinoma tumor progression[J].Cancer Research,2009,(14):5707-5715.doi:10.1158/0008-5472.CAN-08-4905.
  • 4Song EY,Qu CF,Rizvi SM. Bismuth-213 radioimmunotherapy with C595 anti-MUC1 monoclonal antibody in an ovarian cancer ascites model[J].Cancer Biology and Therapy,2008,(01):76-80.doi:10.4161/cbt.7.1.5132.
  • 5Shimizu M,Imai M. Effect of the antibody immunotherapy by the anti-MUC1 monoclonal antibody to the oral squamous cell carcinoma in vitro[J].Biological and Pharmaceutical Bulletin,2008,(12):2288-2293.doi:10.1248/bpb.31.2288.
  • 6Moreno M,Bontkes HJ,Scheper RJ,Kenemans P,Verheijen RH,von Mensdorff-Pouilly S. High level of MUC1 in serum of ovarian and breast cancer patients inhibits huHMFG-1 dependent cell-mediated cytotoxicity(ADCC)[J].Cancer Letters,2007,(01):47-55.doi:10.1016/j.canlet.2007.06.016.
  • 7Mehmet H. Apoptosis:caspase find a new place to hide[J].Nature,2000,(6765):29-30.doi:10.1038/47377.
  • 8Ghicelli L,Diederich M. Multistep and multitask Bax activation[J].Mitochondrion,2010,(06):604-613.
  • 9Xiao G,Fang H,Xing C. Structure,function and inhibition of Bcl-2 family proteins:a new target for anti-tumor agents[J].Mini Reviews in Medicinal Chemistry,2009,(14):1596-1604.doi:10.2174/138955709791012238.
  • 10Rolland SG,Conradt B. New role of the BCL2 family of proteins in the regulation of mitochondrial dynamics[J].Current Opinion in Cell Biology,2010,(06):852-858.doi:10.1016/j.ceb.2010.07.014.

同被引文献2

  • 1Elisabeth Quoix,Rodryg Ramlau,Virginie Westeel,Zsolt Papai,Anne Madroszyk,Alain Riviere,Piotr Koralewski,Jean-Luc Breton,Erich Stoelben,Denis Braun,Didier Debieuvre,Hervé Lena,Marc Buyse,Marie-Pierre Chenard,Bruce Acres,Gisèle Lacoste,Bérangère Bastien,Annette Tavernaro,Nadine Bizouarne,Jean-Yves Bonnefoy,Jean-Marc Limacher.Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial[J].Lancet Oncology.2011(12)
  • 2李娜,孙志伟,俞炜源.CpG免疫刺激DNA序列及其在疫苗佐剂中的应用[J].生物技术通讯,2008,19(4):572-575. 被引量:4

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部